ABG Sundal Collier acted as Sole Global Coordinator and Sole Bookrunner in the SEK 334m IPO of IRRAS on First North Premier

IRRAS has successfully completed its IPO and started trading on First North Premier on 22 November. The Final offering price was SEK 45 per share, which corresponds to net proceeds of SEK 263 million before exercise of over-allotment option. The proceeds is intended to be used to accelerate sales in the EU and enter the US following approval from FDA, as well as expand applications for the existing flagship technology platform IRRAflowTM into new applications in neurosurgery, body pathologies and drug delivery.